CD20 & CD22
Predicted to enable CD4 receptor binding activity; protein phosphatase binding activity; and sialic acid binding activity. Involved in B cell activation; negative regulation of B cell receptor signaling pathway; and regulation of endocytosis. Located in early endosome and recycling endosome.
This gene encodes a member of the membrane-spanning 4A gene family. Members of this nascent protein family are characterized by common structural features and similar intron/exon splice boundaries and display unique expression patterns among hematopoietic cells and nonlymphoid tissues. This gene encodes a B-lymphocyte surface molecule which plays a role in the development and differentiation of B-cells into plasma cells. This family member is localized to 11q12, among a cluster of family members. Alternative splicing of this gene results in two transcript variants which encode the same protein.
-
- Targets: CD20 & CD22
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD20 & CD22
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Species Reactivity: Mouse
- Type: Human IgG1
- Application: Depletion, FuncS, WB, FC, IF
Compare
-
- Derivation: Hybridoma
- Species Reactivity: Canine
- Type: Mouse IgG
- Application: ELISA, WB
Compare
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: ELISA, SPR
Compare
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA
Compare
-
- Species Reactivity: Human
- Type: Mouse IgG2b
- Application: FC, Cyt, Block, Apop, ROS assay, FuncS
Compare
-
Compare
-
Compare
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: FC, ELISA, SPR, FuncS
Compare
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric antibody (mouse/human)
- Application: ELISA
Compare
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: IF, FC
Compare
-
Compare
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: Block, Cyt, ELISA, FuncS
Compare
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) Fab
- Application: Inhib
Compare
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: Inhib
Compare
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
Compare
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
Compare
-
- Derivation: Human
- Type: Fully human antibody
Compare
-
- Derivation: Human
- Type: Fully human antibody
Compare
-
- Derivation: Human
- Type: Fully human antibody
Compare
-
- Derivation: Human
- Type: Fully human antibody
Compare
-
- Derivation: Human
- Type: Fully human antibody
Compare
-
- Derivation: Human
- Type: Fully human antibody
Compare
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, WB
Compare
-
- Application: ELISA, In vivo
Compare
-
- Application: ELISA, In vivo
Compare
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: IF, FC
Compare
-
Compare
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: Block, Cyt, ELISA, FuncS
Compare
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Inhib
Compare
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Inhib
Compare
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
Compare
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
Compare
-
- Derivation: Human
- Type: Fully human antibody
Compare
-
- Derivation: Human
- Type: Fully human antibody
Compare
-
- Derivation: Human
- Type: Fully human antibody
Compare
-
- Derivation: Human
- Type: Fully human antibody
Compare
-
- Derivation: Human
- Type: Fully human antibody
Compare
-
- Derivation: Human
- Type: Fully human antibody
Compare
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, WB
Compare
-
- Application: ELISA, In vivo
Compare
-
- Application: ELISA, In vivo
Compare
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG
- Application: IF, FC
Compare
-
Compare
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG
- Application: Block, Cyt, ELISA, FuncS
Compare
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG1, κ
- Application: Inhib
Compare
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
Compare
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
Compare
-
- Derivation: Human
- Type: Fully human antibody
- Application: ELISA
Compare
-
- Derivation: Human
- Type: Fully human antibody
- Application: ELISA
Compare
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
Compare
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
Compare
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
Compare
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
Compare
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, WB
Compare
-
- Application: ELISA, In vivo
Compare
-
- Application: Inhib, Cyt, FC, WB
Compare
-
- Target: CD22
- Linker: vc (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
Compare
-
- Target: CD22
- Linker: acetyl butyrate linker
- Drug: calicheamicin
Compare
-
- Target: CD22
- Linker: mc(maleimidocaproyl)
- Drug: MMAF (monomethyl auristatin F)
Compare
-
- Target: CD22
- Linker: mc-VC-PABC(maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
Compare
-
- Target: CD22
- Linker: MCC(Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
Compare
-
- Target: CD22
- Linker: SPP(N-succinimidyl-4-(2-pyridyldithio)pentanoate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
Compare
-
- Target: CD22
- Drug: saporin
Compare
-
- Target: CD22
- Linker: mc-VC-PABc (maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: NMS249
Compare
-
- Target: CD22
- Linker: mc-VC-PABc(maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
Compare
-
- Target: CD22
- Linker: MCC (4-(N-maleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
Compare
-
- Target: CD22
- Linker: AcBut (4-(4-acetylphenoxy)butanoic acid)
- Drug: CalichDMH
Compare
-
- Target: CD22
- Linker: AcBut (4-(4-acetylphenoxy)butanoic acid)
- Drug: CalichDMH
Compare
-
- Target: CD22
- Linker: DIBO (dibenzylcyclooctynol)
- Drug: doxorubicin
Compare
-
- Target: CD22
- Linker: hydrazone
- Drug: Calicheamicin
Compare
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
Compare
-
- Target: CD22
- Linker: mcc (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
-
- Target: CD22
- Linker: CL2E
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
Compare
-
- Target: CD22
- Linker: CL2A
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
Compare
-
- Target: CD22
- Linker: AcBut
- Drug: Calicheamicin
Compare
-
- Target: CD22
- Linker: mcc (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
Compare
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
Compare
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
Compare
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
Compare
-
- Target: CD22
- Linker: SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
Compare
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
-
- Target: CD22
- Linker: BMPEO (bis-maleimido-trioxyethylene glycol)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
-
- Target: CD22
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
Compare
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
For Research Use Only. Not For Clinical Use.